X4 Pharmaceuticals announced a virtual Investor Day on October 29, 2026, focusing on mavorixafor as a treatment for chronic neutropenia. The event will include updates on the Phase 3 4WARD trial and plans for a Phase 2 trial combining mavorixafor with G-CSF to reduce G-CSF dosage while maintaining neutrophil counts. Key opinion leaders in hematology will join management for discussions and a Q&A session. This highlights X4's ongoing efforts to advance treatments for rare blood disorders and explore commercial opportunities for mavorixafor.
X4 Pharmaceuticals' upcoming virtual Investor Day is the subject here. For readers following the health sector, of 128 priced US health stocks tradable on Pluang, 66 rose and 52 fell today. Notable movers include DFTX at USD 35.95 with a 1-day change of +5.18%, DNA at USD 11.91 up +5.03%, and INO at USD 1.14 up +4.59%. This data is as of Oct 09, 2026 17:11 WIB.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...
A decade-old bug in the XRP Ledger's payment system could have allowed attackers to create and spend new XRP tokens without funding them, violating the fixed supply of 100 billion XRP. The vulnerability involved a counting error in the ledger's built...
Coinbase's spot Bitcoin order book revealed a significant sell order of 61.63 BTC valued at about $5.1 million, placed slightly above the market midpoint price of $82,523. Nearby sell orders total approximately $23.4 million, while buy orders are clo...
BlackRock's iShares Bitcoin Trust (IBIT), the largest US spot Bitcoin ETF, recorded a $22.38 million net inflow on October 9, 2026, following a significant $207.7 million outflow two days earlier. The fund holds actual Bitcoin through Coinbase Prime ...
U.S. spot Bitcoin ETFs recorded a net inflow of $21.1 million on October 9, reversing the previous day's $244.1 million outflow. BlackRock’s iShares Bitcoin Trust led with $22.4 million in inflows, while Fidelity’s Wise Origin Bitcoin Fund saw a $3.6...
